Announcing the release of the Roadmap for the Treatment of Pediatric DMG today in Cancer Cell which was led by Vennetilab and Koschmann Lab and put together by the brilliant team of researchers who came together for the ChadTough Defeat DIPG Foundation Defeat DIPG Workshop: sciencedirect.com/science/articl…

So happy to share our consensus paper on understanding and treating #DIPG from the ChadTough Defeat DIPG Foundation foundation workshop held this year in #AnnArbor. Thank you to our amazing scientists, collaborators, and families who made this possible!!! cell.com/cancer-cell/fu…

We're excited to share this roadmap that was put together by researchers who attended our 2023 Research Workshop!

C.S. Mott Children's Luanne Thomas Ewald Davis Warren So honored to receive this support from #UCanCerVive on behalf of Koschmann Lab! Will get right to work on our shared commitment to improve treatments for children with brain tumors.

Honored to be included in this incredible group and excited to get to work with our collaborators Efrat Shema and Guy Ron. Thanks as always to the incredible ChadTough Defeat DIPG Foundation foundation!!! U-M Rogel Cancer Center Weizmann Institute Hebrew University

Another incredible ChadTough Defeat DIPG Foundation Run Tough 5K today. Amazing showing by Michigan Medicine labs Vennetilab Koschmann Lab @johnprensner, Children’s CTSU, and C.S. Mott Children's employees and families - all for the most important cause- defeating DIPG.

Super congrats to Sunny for this Fellowship award! Sunny is an outrageously talented MD/PhD student working on understanding ONC201 and associated resistance mechanisms. Really excited to put this money to good use!

Amazing! So happy to host Dani (de la Nava) who is a freshly graduated PhD rockstar from the Advanced Therapies for Pediatric Solid Tumors Lab. Dani is using these funds to study biofluids (CSF/plasma) from patients on the IL13Ra2 CAR-T trial to identify patterns of response/resistance. Congrats Dani!

HUGE congrats to the Brenner Lab! Anyone in this space knows how hard CLIA validation is, and this was a heroic effort. We're hard at work collaborating with this team to validate our best-in-class H3K27M ddPCR plasma test. Hoping to offer our test to patients later this year!

Congrats Kallen! Carl Koschmann s first PhD student is PhDONE! Not only that but Kallen's premiere first author thesis work is out today in @CancerCell in collaboration with Mariella Filbin Johannes Gojo Amazing work! cell.com/cancer-cell/fu…